How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial

INTRODUCTION: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and most patients in China are diagnosed at the intermediate or later stages, which is not suitable for the first line therapies. Transarterial chemoembolization (TACE) is a commonly selected therapeutic op...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yi, Chang, Rui, He, Zhonglin, Hong, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545327/
https://www.ncbi.nlm.nih.gov/pubmed/33832116
http://dx.doi.org/10.1097/MD.0000000000025360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545327/
https://www.ncbi.nlm.nih.gov/pubmed/33832116
http://dx.doi.org/10.1097/MD.0000000000025360

Ejemplares similares